Skip to main content
. 2019 Aug 2;35(7):1153–1172. doi: 10.1007/s00467-019-04304-9

Fig. 2.

Fig. 2

Impact of CKD and diarrhea on tacrolimus bioavailability. CKD chronic kidney disease, CYP cytochrome P450 enzyme